Data is not available at this time.
Suntar Environmental Technology operates as a specialized provider of advanced membrane separation solutions within China's industrial water treatment sector. The company generates revenue through the development, manufacturing, and sale of proprietary membrane technologies including ceramic, spiral, hollow fiber, and PP/PE membranes, along with integrated systems like membrane bioreactors and solvent recovery units. Serving critical industries such as pharmaceuticals, biotechnology, chemical engineering, and food and beverage processing, Suntar positions itself as a technology-driven specialist rather than a broad utilities provider. The company's market position leverages China's stringent environmental regulations and growing demand for efficient water treatment solutions in industrial applications. By focusing on high-performance membrane separation technologies, Suntar differentiates itself from conventional water treatment companies and targets niche industrial segments requiring precise separation processes. This specialization allows the company to maintain technological barriers to entry while addressing specific customer needs in regulated processing environments.
The company reported revenue of CNY 1.39 billion with net income of CNY 314.8 million, achieving a healthy net margin of approximately 22.6%. Operating cash flow of CNY 171.9 million demonstrates solid cash generation, though capital expenditures of CNY 100.6 million indicate ongoing investment in production capacity and technological development to maintain competitive positioning.
Suntar exhibits strong earnings power with diluted EPS of CNY 0.95, reflecting efficient capital allocation in its specialized membrane technology business. The company's focused industrial approach generates robust returns on its technology investments, though the capital-intensive nature of membrane manufacturing requires continuous R&D and production optimization to sustain competitive advantages.
The balance sheet remains conservative with CNY 571.3 million in cash and equivalents against minimal total debt of CNY 62.1 million, indicating strong liquidity and low financial leverage. This prudent financial structure provides flexibility for strategic investments and technology development while weathering industry cyclicality.
The company maintains a balanced capital return policy, distributing CNY 0.23 per share in dividends while retaining earnings for growth initiatives. This approach supports both shareholder returns and funding for expansion in China's growing industrial water treatment market, particularly in regulated sectors requiring advanced separation technologies.
With a market capitalization of CNY 5.5 billion, the market appears to value Suntar's specialized technology positioning and growth potential in China's environmental sector. The low beta of 0.186 suggests investors perceive the company as relatively defensive within the utilities segment, reflecting its niche industrial focus rather than broad utility exposure.
Suntar's strategic advantage lies in its specialized membrane technology expertise and focus on high-value industrial applications. The company is well-positioned to benefit from China's increasing environmental regulations and industrial upgrading, though it faces competition from both domestic and international membrane technology providers in this evolving market.
Company financial reportsStock exchange disclosuresCompany description and financial data provided
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |